Βαλβιδοπάθειες. Από ηις τειροσργικές ζηις διαδερμικές θεραπείες
|
|
- Barnard Dennis
- 5 years ago
- Views:
Transcription
1 Βαλβιδοπάθειες. Από ηις τειροσργικές ζηις διαδερμικές θεραπείες Ιωάννης Δ. Κανονίδης Καθηγηηής Καρδιολογίας Α.Π.Θ. Γιεσθσνηης Β Καρδιολογικής Κλινικής Α.Π.Θ. Γενικό Νοζοκομείο Θεζζαλονίκης «Ιπποκράηειο»
2 Cardiac Surgery
3 Any surgeon attempting an operation of the heart would lose the respect of his colleagues Theodor Billroth (1883)
4 In 1923 Dr. Elliott Cutler of the Peter Bent Brigham Hospital performed the world s first successful heart valve surgery - a mitral valve repair. The patient was a 12- year-old girl with rheumatic mitral stenosis.
5 In 1925 Henry Souttar operated successfully on a young woman with mitral stenosis. He made an opening in the appendage of the left atrium and inserted a finger into this chamber in order to palpate and explore the damaged mitral valve. The patient survived for several years Souttar s physician colleagues at that time decided the procedure was not justified and he could not continue.
6 Cardiac surgery changed significantly after World War II In 1948 four surgeons working independently of each other carried out successful operations for mitral stenosis due to rheumatic fever. Horace Smithy ( ) of Charlotte, revived an operation due to Dr Dwight Harken of the Peter Bent Brigham Hospital using a punch to remove a portion of the mitral valve. Charles Bailey ( ) at the Hahnemann Hospital, Philadelphia, Dwight Harken in Boston Russell Brock at Guy s Hospital All adopted Souttar s method. All these men started work independently of each other, within a few months. This time Souttar s technique was widely adopted although there were modifications.
7
8 First Aortic Valve Replacement Murray, in Toronto considered replacing a diseased valve with a valve taken from a donor animal. Encouraged by results of his experiments with dogs he implanted a valve harvested from a human cadaver into descending thoracic aorta of a 22 Yr. man who had severe AR. This man was a manual worker & was asymptomatic when seen 6 Yrs later First Aortic Valve Repair May Dr. Lillehei repaired an Aortic Valve in a female patient on the heart-lung machine
9 Mechanical prostheses Mitral Valve First implant was done in early 1960 s in USA Aorta First Aortic prosthesis implant performed on a patient in March 1960 in Florida, USA Double Valve Surgery First Double Valve Implant was performed in November 1961 in Pittsburgh, Pennsylvania, USA
10 Πρώηη Γενιά Τεχνηηών Καρδιακών Βαλβίδων Star-Edwards: Κλωβού και ζθαίρας First implanted by Starr and Harken in 1960.
11
12 Miles "Lowell" Edwards
13 Ball-and-Cage Valves Opening and closure of the ball-valve
14 Δεύηερη Γενιά Τεχνηηών Καρδιακών Βαλβίδων Star-Edwards: Lillehei-Kaster: 1967 Carpentier-Edwards: 1968 Βιοπρόζθεζη Hancock I: 1969 Βιοπρόζθεζη Jonescn-Shiley: Bjork-Shiley: St. Jude Medical: Βιοπρόζθεζη 1969 BSST 1980 BSCC 70
15 Τρίηη Γενιά Τεχνηηών Καρδιακών Βαλβίδων St. Jude Medical: 1977 Medtronic-Hall: 1977 M-H-1980 Bjork-Shiley Monostrut: 1982 (απεζύρθη) Omniscience: 1978 Duromedics: 1981 Carpentier-Edwards: 1981 Βιοπρόζθεζη Hancock ΙI: 1982 Βιοπρόζθεζη Carbomedics Inc.: 1986 Omnicarbon: 1984
16 Types of Prosthetic Heart Valves I Caged-ball Starr-Edwards Braunwald-Cutter Smeloff-Cromie
17 Types of Prosthetic Heart Valves II Tilting-disk Björk-Shiley Björk-Shiley convexoconcave Medtronic-Hall Lillihei-Kaster Omniscience Sorin
18 Bjork-Shiley Bjork-Shiley Bjork-Shiley in the Mitral position
19 Types of Prosthetic Heart Valves III Bileaflet St. Jude Medical Carbomedics Duromedics
20 St. Jude valve St. Jude valve in the mitral position.
21 Flow Dynamics
22 Mechanical valves Designs and flow patterns of different types of mechanical valves
23 Types of prosthetic valves and thrombogenicity Type of valve Model Thrombogenicity Mechanical Caged ball Starr-Edwards Single tilting disc Bjork-Shiley, Medtronic Hall Bileaflet Bioprosthetic Heterografts St Jude Medical, Sorin Bicarbon, Carbomedics + + Carpentier-Edwards, Tissue Med (Aspire), Hancock II + to + + Homografts +
24 Ideal valve Good hemodynamic Quiet Require no anticoagulation Last for life time Cheap Easy to implant
25 Mechanical Valves Extremely durable with overall survival rates of 94% at 10 years Primary structural abnormalities are rare Most malfunctions are secondary to perivalvular leak and thrombosis Chronic anticoagulation required in all With adequate anticoagulation, rate of thrombosis is 0.6% to 1.8% per patient-year for bileaflet valves
26 Homografts first aortic valve homograft was used in the descending thoracic aorta for aortic regurgitation In 1962 Alfred Gunning & co-workers in Oxford worked out a reliable method for aortic homograft harvest & preparation. This allowed Ross to perform the first landmark sub-coronary homograft implantation in This success was soon followed by Barrat-Boyce in New Zealand, Mattias Paneth & Mark O Brien at Brompton hospital. Alfred Gunning These were the people who adopted & pioneered homograft aortic replacement at a time when most surgeons preferred the durability & simplicity of Starr Edward valve insertion with a single row of sutures. The homograft insertion was technically more demanding in an era when myocardial preservation was primitive.
27 DEVELOPMENT OF PORCINE BIOPROSTHESIS In 1964 after their succes with homografts, Gunning & Duran diverted their attention to preservation of heteregenous valves. In the same year they performed first human stent mounted porcine valve implantation In 1965 Duran & Carpentier presented their experience of mercurochrome preserved frame mounted heterografts. This was soon followed by reports by Mark O Brien about his experience with formalin preserved pig & calf aortic heterografts. However, long term results were poor because of primitive preservation methods
28 Marion Ionescu ( Leeds) In 1966 Ionescu developed a stent for mounting aortic heterograts. It had Titanium support, 3 legs covered with dacron velour & dacron felt ring was used as a sewing ring. The porcine aortic valve was sutured within the frame.
29 Carpentier next produced a stent made of stainless steel coated with Teflon to minimise thromboembolism & he used mercurial salt for tissue preservation. This stent is the precursor of stent used in modern Carpentier- Edward valve Within 5 yrs of use of stented valves it was realised that stent mounting caused excessive stress on the biological tissue which resulted in accelerated degeneration. This setback caused practice of stent mounting to disappear.
30 1968 -Preservation of tissues with formaldehyde or mercurochrome was proving disappointing, this problem was soon resolved by Carpentier who employed gluteraldehyde preservation for the first time. The chemical treatment of tissues prevents collagen denaturation & reduces antegenicity of foreign tissues
31
32 AUTOGRAFTS ROSS OPERATION In 1967 Ross performed the first pulmonary autograft operation for aortic valve replacement. Initially autogenous pulmonary valve was used as a sub- coronary implant & later as a full aortic root replacement. Ross anticipated that autologus pulmonary valve will remain viable & maintain potential for growth in children. Experience have shown this to be true. Whilst Ross persisted with his operation others were reluctant to perform a complex double root replacement for isolated aortic disease which otherwise could be treated with very low morbidity & mortality with a stented valve. is to be true.
33 DEVELOPMENTS IN REPLACEMENT OF MITRAL VALVE Ross attempted to replace mitral valve with a mitral homograft. Though early post-operative hemodynamics were excellent, most patients sustained rupture of chordae tendeniae within a few months of operation. In addition proper placement of papillary muscles inside LV required considerable judgment & skills. Because of these reasons MV homografts replacement has never regained wide spread acceptance.
34 STENTLESS VALVES In 1988 Tyrone David re-explored the use of stentless gluteraldehyde fixed aortic xenograft. Hemodynamic evaluation showed very small gradients & minimal regurgitation in early implants.
35 Stentless Valves Medtronic Freestyle St. Jude Toronto SPV
36 Bioprosthetic Bioprosthetic Valve types: heterografts, homografts advantage: short term anticoagulation limitation: structural failure leaflet calcification & tissue degeneration leading to valvular regurgitation rate of porcine valve degeneration 26% (aortic), 39% (mitral) in 10 yrs
37 Biologic (Tissue) Stented Porcine xenograft Pericardial xenograft Stented bioprostheses Primary mechanical failure at 10 years is 15-20% Preferred in patients over age 70 Subject to progressive calcific degeneration & failure after 6-8 years
38 Types of Bioprosthetic Valves I Porcine (stented) Hancock I Hancock II Hancock MO (modified orifice) Carpentier-Edwards C/E Duraflex Medtronic Intact Bioimplant
39 Types of Bioprosthetic Valves II Pericardial Ionescu-Shiley Carpentier-Edwards pericardial Mitroflow
40 Biological Valves Stentless Porcine xenograft Pericardial xenograft Stentless bioprostheses Absence of stent & sewing cuff allow implantation of larger valve for given annular size->greater EOA Uses the patient s own aortic root as the stent, absorbing the stress induced during the cardiac cycle
41 Biologic Valves Continued Homografts Harvested from cadaveric human hearts Advantages: resistance to infection, lack of need for anticoagulation, excellent hemodynamic profile (in smaller aortic root sizes) More difficult surgical procedure limits its use Autograft Ross Procedure
42
43
44 Mitral valve repair CARPENTIER CLASSIFICATION
45 Τεχνικές Διόρθωσης Μιτροειδούς Βαλβίδας Δακτύλιος α) Tοποθέηηζη δακηςλίος (Carpentier, Duran, Cosgrove) β) Δακηςλιοπλαζηική Γλωχίνες Μεπική εκηομή και ζςππαθή ή μόνο πλαζηική μεηάθεζη σοπδών επί πήξεωρ αςηών, ζμίκπςνζη σοπδών ή θηλοειδών μςών επί επιμηκύνζεωρ αςηών. Κινηηοποίηζη γλωσίνων καηόπιν εκηομήρ σοπδών ηηρ βάζηρ ή δεςηεπεςόνηων. Yποβαλβιδικός μηχανισμός Κινηηοποίηζη ηος ςποβαλβιδικού μησανιζμού καηόπιν διαίπεζηρ ηων θηλοειδών μςών μέσπι ηη βάζη αςηών, απομάκπςνζη αζβεζηίος.
46
47 Aortic valve repair Aortic valve repair is a surgical procedure used to correct some aortic valve disorders as an alternative to aortic valve replacement. Aortic valve repair is performed less often and is more technically difficult than mitral valve repair. There are two surgical techniques of aortic-valve repair: The Reimplantation-Technique (David-Procedure) The Remodeling-Technique (Yacoub-Procedure)
48 Minimally invasive Cardiac Surgery Endoscopic or robotic heart surgery. Hugo Vanerman (Belgium). In minimally invasive valve surgery, long-handled tools are inserted into the chest through four or more small incisions. While watching a video monitor, the surgeon manipulates the tools and conducts the surgery. In some cases, robotic arms may be used to manipulate the tools for the surgeon. Only some hospitals can offer minimally invasive valve surgery. Cardiac surgeons are not unanimous about the relative merits of sternotomy versus the minimally invasive approach. The minimally invasive approach can produce a less prominent scar, is beneficial for very obese patients, and may allow the patient to return to their normal activity sooner than a sternotomy.
49 VALVES AND INTERVENTIONAL CARDIOLOGY
50 Balloon Valvuloplasty Valvuloplasty is the widening of a stenotic valve using a balloon catheter. Types include: Aortic valvuloplasty in repair of a stenotic aortic valve Mitral valvuloplasty in the correction of an uncomplicated mitral valve Pulmonary valvuloplasty
51 Percutaneous mitral valvuloplasty 1.Single large balloon 2.Double balloon 3.Multi Track System (P. Bonhoeffer) 4.Innoue balloon
52 Inn-oue balloon Valvuloplasty of the Mitral Valve." The balloon is sub-divided into 3 segments and is dilated in 3 stages. 1st the distal portion (lying in the left ventricle) is inflated and pulled against the valve cusps. 2nd the proximal portion is dilated, in order to fix the centre segment at the valve orifice. Finally, the central section is inflated, This should take no longer than 30 seconds since full inflation obstructs the valve and causes congestion, leading to circulatory arrest and flash pulmonary edema.
53 Aortic balloon valvuloplasty 1.Anterograde approach (transeptal) 2.Retrograde approach
54 Percutaneous valve replacement 1.Bonhoeffer: pulmonary (2000) 2.Al. Cribier: aortic (2002)
55
56 The SAPIEN valve Lifesciences. made by Edwards The CoreValve system made by Medtronic
57 Percutaneous aortic valve replacement Implants the valve using a catheter, without open heart surgery. It is used in more than 50 countries in patients who are at extreme or high risk to undergo open heart surgery In high-risk patients with severe aortic stenosis, transcatheter and surgical procedures for aortic-valve replacement had similar rates of survival at 1 year, although there were important differences in risks associated with the procedure. [2] The transcatheter procedure was associated with a higher risk of stroke than the surgical replacement (5.5% vs. 2.4% after 30 days; 8.3% vs. 4.3% after 1 year). [3]
58 Mitral Valve Clip
59 Feldman (2005)
60 What about the futur?
61 Thank you!
62 Prosthetic Valves are classified as tissue or mechanical Tissue: Actual valve or one made of biologic tissue from an animal (bioprosthesis or heterograft) or human (homograft or autograft) source Mechanical Made of nonbiologic material (pyrolitic carbon, polymeric silicone substances, or titanium) Blood flow characteristics, hemodynamics, durability, and thromboembolic tendency vary depending on the type and size of the prosthesis and characteristics of the patient
Echo Evaluation of a Mitral Valve Prostheses Sunday, February 14, :50 2:10 PM 20 min
2016 ASE State of the Art Echocardiography Course Tucson, AZ Echo Evaluation of a Mitral Valve Prostheses Sunday, February 14, 2016 1:50 2:10 PM 20 min 1 M U H A M E D S A R I Ć, M D, P H D D i r e c t
More informationHemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves
Hemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves Speaker's name: I have the following potential conflicts of interest to report: Proctorship for Medtronic Agenda Failure modes
More informationTSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD
TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)
More informationHeart Valve Replacements From the Old to. the New
Heart Valve Replacements From the Old to Timothy P. Obarski, DO, FACC, FACP Director of Echocardiography Assistant professor of Medicine Division of Cardiology The Ohio State Wexner Medical Center Columbus,
More informationEchocardiographic Evaluation of Mitral Valve Prostheses
Echocardiographic Evaluation of Mitral Valve Prostheses Dennis A. Tighe, M.D., FACC, FACP, FASE Cardiovascular Medicine University of Massachusetts Medical School Worcester, MA www.asecho.org 1 Nishimura
More informationSurgical Treatment for Valvular Heart Disease
Chapter 34 Surgical Treatment for Valvular Heart Disease Peter J. K. Starek Competency of the atrioventricular valves allows blood to enter the ventricles, where pressure is generated. When adequate systolic
More informationIatrogenic pathology of the heart:
Iatrogenic pathology of the heart: Complications of mitral valve plasty and replacement Patrick Bruneval D pt of Pathology Hôpital Européen Georges Pompidou Enterprise Interest None Mitral valve surgery
More informationCoreValve in a Degenerative Surgical Valve
CoreValve in a Degenerative Surgical Valve Ran Kornowski, MD, FESC, FACC Chairman Department of Cardiology Rabin Medical Center, Petach Tikva, Israel Disclosure Statement of Financial Interest I, Ran Kornowski,
More information2017 Cardiovascular Symposium CARDIAC SURGERY UPDATE: SMALLER INCISIONS AND LESS COUMADIN DAVID L. SAINT, MD
2017 Cardiovascular Symposium CARDIAC SURGERY UPDATE: SMALLER INCISIONS AND LESS COUMADIN DAVID L. SAINT, MD David L Saint M.D. Tallahassee Memorial Hospital Southern Medical Group Division of Cardiothoracic
More informationHeart Valves: Before and after surgery
Heart Valves: Before and after surgery Tim Sutton, Consultant Cardiologist Middlemore Hospital, Auckland Auckland Heart Group Indications for intervention in Valvular disease To prevent sudden death and
More informationLate failure of transcatheter heart valves: An open question
Late failure of transcatheter heart valves: An open question A comparison with surgically implanted bioprosthetic heart valves. A. Rashid The Cardiothoracic Centre Liverpool, UK. Conflict of Interest Statement
More informationRESEARCH AND REVIEWS: JOURNAL OF PHARMACOLOGY AND TOXICOLOGICAL STUDIES
e-issn:2322-0139 RESEARCH AND REVIEWS: JOURNAL OF PHARMACOLOGY AND TOXICOLOGICAL STUDIES Comparative Evaluation of Safety Outcomes of Different Prosthetic Valves in Indian Subjects. Kama Raval 1 *, Reena
More informationAdult Cardiac Surgery
Adult Cardiac Surgery Mahmoud ABU-ABEELEH Associate Professor Department of Surgery Division of Cardiothoracic Surgery School of Medicine University Of Jordan Adult Cardiac Surgery: Ischemic Heart Disease
More informationTAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?
TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair? Elaine E. Tseng, MD and Marlene Grenon, MD Department of Surgery Divisions of Adult Cardiothoracic and Vascular and Endovascular
More informationSpotlight on valvular heart disease guidelines. Prosthetic heart valves. Bernard Iung Bichat Hospital, Paris Diderot University Paris, France
Spotlight on valvular heart disease guidelines. Prosthetic heart valves. Bernard Iung Bichat Hospital, Paris Diderot University Paris, France Faculty disclosure First name - last name I disclose the following
More informationHardware in the Chest - From VADs to Valves
Hardware in the Chest - From VADs to Valves Cristina Fuss, MD Purpose Recognize the device Indication and function Cristina Fuss, MD Department of Diagnostic Radiology FROM VADS TO VALVES Implanting technique
More informationPROSTHETIC. V PROSTHETIC.V
PROSTHETIC. V PROSTHETIC.V VALVE TYPE The valve types now implanted include: 1-bileaflet and tilting disc mechanical valves, 2-stented porcine and pericardial xenografts, 3-stentless porcine xenografts,
More informationTranscatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital,
Transcatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital, Oslo, Norway Aortic regurgitation Prevalence in Framingham
More informationCardiac Valve/Structural Therapies
Property of Dr. Chad Rammohan Cardiac Valve/Structural Therapies Chad Rammohan, MD FACC Medical Director, El Camino Hospital Cardiac Catheterization Lab Director, Interventional and Structural Cardiology,
More information25 different brand names >44 different models Sizes mm
Types of Prosthetic Valves BIOLOGIC STENTED Porcine xenograft Pericardial xenograft STENTLESS Porcine xenograft Pericardial xenograft Homograft (allograft) Autograft PERCUTANEOUS MECHANICAL Bileaflet Single
More information42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim
42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim Current Guideline for AR s/p TOF Surgery is reasonable in adults with prior repair of
More informationValvular Heart Disease
Valvular Heart Disease B K Singh, MD, FACC Disclosures: None 1 CARDIAC CYCLE S2 S2=A2P2 S1=M1T1 S4 S1 S3 2 JVP Carotid S1 Slitting of S2 S3 S4 Ejection click Opening snap Dynamic Auscultation What is the
More informationTreatment of Bio-Prosthetic Valve Deterioration Using Transcatheter Techniques
Treatment of Bio-Prosthetic Valve Deterioration Using Transcatheter Techniques Pablo Codner, Abid Assali, Hanna Vaknin-Assa, Katia Orvin, Ram Sharony, Leor Perl, Gabriel Greenberg, Marina Kupershmidt,
More informationPercutaneous Therapy for Calcific Mitral Valve Disease
31 st Annual State of the Art Echocardiography San Diego, CA February 18, 2018 5:00 5:15 PM 15 min Percutaneous Therapy for Calcific Mitral Valve Disease Muhamed Sarić MD, PhD, MPA Director of Noninvasive
More informationManagement of Difficult Aortic Root, Old and New solutions
Management of Difficult Aortic Root, Old and New solutions Hani K. Najm MD, Msc, FRCSC,, FACC, FESC Chairman, Pediatric and Congenital Heart Surgery Cleveland Clinic Conflict of Interest None Difficult
More informationHow Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, :00 11:25 PM 25 min
2016 ASE State of the Art Echocardiography Course Tucson, AZ How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, 2016 11:00 11:25 PM 25 min 1 M U H A M E D S A R I Ć, M D, P H D
More informationProsthetic valve dysfunction: stenosis or regurgitation
Prosthetic valve dysfunction: stenosis or regurgitation Jean G. Dumesnil MD, FRCP(C), FACC, FASE(Hon) Quebec Heart and Lung Institute, Québec, Québec No disclosures Possible Causes of High Gradients in
More informationPATIENT BOOKLET MEDTRONIC SURGICAL VALVE REPLACEMENT. Tissue Valve for Aortic and Mitral Valve Replacement
PATIENT BOOKLET MEDTRONIC SURGICAL VALVE REPLACEMENT Tissue Valve for Aortic and Mitral Valve Replacement ARE MEDTRONIC SURGICAL TISSUE HEART VALVES RIGHT FOR YOU? Medtronic surgical heart valves are for
More informationAortic stenosis and regurgitation
1 Aortic stenosis and regurgitation valvuloplasty and replacement Mitral regurgitation and stenosis valvuloplasty and repair/replacement 2 ASD PFO VSD PDA occlusion Left atrial appendage occlusion for
More informationTransapical Transcatheter Aortic Valve Implantation in the Presence of a Mitral Prosthesis
Journal of the American College of Cardiology Vol. 58, No. 7, 2011 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.04.023
More informationBiological or mechanical valve prosthesis?
XXIX Giornate Cardiologiche Torinesi ADVANCES IN CARDIAC ARRHYTHMIAS AND GREAT INNOVATIONS IN CARDIOLOGY Turin, October 27-28, 2017 Centro Congressi Unione Industriale WHAT HAS CHANGED IN CARDIAC SURGERY?
More informationI will not discuss off label use or investigational use in my presentation.
I will not discuss off label use or investigational use in my presentation. Surgical valves Design and Durability Testing Potential Concerns Real Practice 1952-1962 1963-1966 1967-1969 1969-1977 1977-1984
More informationStainless Steel. Cobalt-chromium
Sapien is better than Corevalve! Raj R. Makkar, MD Associate Director, Cedars-Sinai Heart Institute Associate Professor, UCLA School of Medicine, Los Angeles Eberhard Grube: Pioneer in the field of TAVR
More informationTAVR for Valve-In-Valve. Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology
TAVR for Valve-In-Valve Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology Temple Hearth and Vascular Institute Disclosures: Consultant: Cardiac Assist TAVR for
More informationBioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique
Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique Charanjit S. Rihal MD MBA Professor and Chair Division of Cardiovascular Diseases Mayo Clinic DISCLOSURES
More informationA Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision
A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction
More informationUpdate on Oral Anticoagulation for Mechanical Heart Valves
Update on Oral Anticoagulation for Mechanical Heart Valves Douglas C. Anderson, Pharm.D., D.Ph. Professor and Chair Dept. of Pharmacy Practice Cedarville University School of Pharmacy OHIO SOCIETY OF HEALTH-SYSTEM
More information14 Valvular Stenosis
14 Valvular Stenosis 14-1. Valvular Stenosis unicuspid valve FIGUE 14-1. This photograph shows severe valvular stenosis as it occurs in a newborn. There is a unicuspid, horseshoe-shaped leaflet with a
More informationUNDERSTANDING YOUR HEART VALVE. Mosaic Tissue Valve
UNDERSTANDING YOUR HEART VALVE Mosaic Tissue Valve A Message to You from the Employees at Medtronic, Inc. We understand that having heart valve replacement surgery is an important change in your life.
More informationA Practical Approach to Prosthetic Valves
A Practical Approach to Prosthetic Valves Bonita Anderson DMU (Cardiac), MApplSc (Med Ultrasound), ACS, AMS, FASE https://doi.org/10.1161/circulationaha.108.778886 Disclosures None 1 Know the Product Know
More informationHani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz
Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for
More informationThe St. Jude Medical Biocor Bioprosthesis
The St. Jude Medical Biocor Bioprosthesis Clinical Evidence of Long-term Durability Long-term Biocor Experience A Review and Comparative Assessment Long-term Biocor Stented Tissue Valve Studies Twenty-year
More informationInterventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504
Transcatheter valve-in-valve e implantation for aortic bioprosthetic valve dysfunction Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Your responsibility This
More informationA brief history of valvular surgery
Cardiac surgery Valvular heart disease University of Pecs, Medical Faculty Heart Institute A brief history of valvular surgery 1925. Souttar closed mitral commissurotomy 1960. McGoon plasty for mitral
More informationPPM: How to fit a big valve in a small heart
PPM: How to fit a big valve in a small heart Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC King Abdulaziz Cardiac Centre National Guard Health Affairs Riyadh, Saudi Arabia GHA meeting Muscat
More informationReplacement Heart Valve Product Description (Stented Tissue) Models Reference
Dear Imaging Center: This letter is in response to your inquiry concerning the safety of performing magnetic resonance (MR) procedures in patients who have been implanted with Edwards Lifesciences LLC
More informationCIPG Transcatheter Aortic Valve Replacement- When Is Less, More?
CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology
More informationMechanical heart valves and Anticoagulation. Dr. Alkesh ZALA Basic Physician trainee, Dept. of Cardiology, John Hunter hospital.
Mechanical heart valves and Anticoagulation Dr. Alkesh ZALA Basic Physician trainee, Dept. of Cardiology, John Hunter hospital. Today s discussion: Case review The currently Available and most commonly
More informationTranscatheter Mitral Valve Replacement How Close Are We?
Transcatheter Mitral Valve Replacement How Close Are We? Gregory Pavlides, MD, PhD, FACC, FESC Professor of Medicine Miscia Chair of Interventional Cardiology Director, Cardiac Catheterization Laboratories,
More informationReplacement Heart Valve Product Description (Stented Tissue) Models Reference
Dear Imaging Center: This letter is in response to your inquiry concerning the safety of performing magnetic resonance (MR) procedures in patients who have been implanted with Edwards Lifesciences LLC
More informationPercutaneous Valve Interventions. Percutaneous Valve Interventions
Percutaneous Valve Interventions Stanton J. Rowe President, Percutaneous Valve Interventions Edwards is Best Positioned to Capitalize on Percutaneous Valve Opportunities #1 global valve replacement and
More information2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route
Transcatheter Aortic Valve Implantation Asian perspective Speakers s name: Paul Chiam Paul TL Chiam MBBS, MRCP, FACC I have the following potential conflicts of interest to report: NONE Consultant National
More informationEjection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.
Valvular Heart Disease Etiology General Principles Cellular and molecular mechanism of valve damage Structural pathology Functional pathology - stenosis/regurgitation Loading conditions - pressure/volume
More informationRole of Sutureless Valves in the Surgeon s Armamentarium Prof. Dr Malakh Shrestha Vice Chair, Director of Aortic Surgery Cardiothoracic,
Role of Sutureless Valves in the Surgeon s Armamentarium Prof. Dr Malakh Shrestha Vice Chair, Director of Aortic Surgery Cardiothoracic, transplantation and Vascular Surgery Hannover Medical School, Germany
More informationEchocardiographic Evaluation of Aortic Valve Prosthesis
Echocardiographic Evaluation of Aortic Valve Prosthesis Amr E Abbas, MD, FACC, FASE, FSCAI, FSVM, RPVI Co-Director, Echocardiography, Director, Interventional Cardiology Research, Beaumont Health System
More informationWorldwide rheumatic fever is the most common cause of valve disease. In industrialized areas, valvular disease of old age predominates
Michael Sumners DO Epidemiology Worldwide rheumatic fever is the most common cause of valve disease In industrialized areas, valvular disease of old age predominates Calcific aortic stenosis Functional
More informationEjection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.
Valvular Heart Disease General Principles Etiology Cellular and molecular mechanism of valve damage Structural pathology Functional pathology - stenosis/regurgitation Loading conditions - pressure/volume
More informationTranscatheter Aortic Valve Replacement
Transcatheter Aortic Valve Replacement Jesse Jorgensen, MD Medical Director, Cardiac Catheterization Laboratory Greenville Health System Greenville, South Carolina, USA January 30, 2016 Aortic Stenosis
More informationTranscatheter valve-in-valve implantation for degenerated surgical bioprostheses
Review Article Transcatheter valve-in-valve implantation for degenerated surgical bioprostheses Dale J. Murdoch, John G. Webb Centre for Heart Valve Innovation, St. Paul s Hospital, Vancouver, Canada Contributions:
More informationExcellence in heart and lung care. Royal Brompton Hospital, Sydney Street, London SW3 6NP
The Surgical Management of the Bicuspid Aortic Valve in Children Professor D.F Shore Royal Brompton & Harefield NHS Trust Excellence in heart and lung care Royal Brompton Hospital, Sydney Street, London
More informationAortic Valve Practice Guidelines: What Has Changed and What You Need to Know
Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know James F. Burke, MD Program Director Cardiovascular Disease Fellowship Lankenau Medical Center Disclosure Dr. Burke has no conflicts
More informationTranscatheter Pulmonary Valve Replacement Update on progress and outcomes
Transcatheter Pulmonary Valve Replacement Update on progress and outcomes Barry Love, MD Director, Congenital Cardiac Catheterization Laboratory Mount Sinai Medical Center New York, New York Transcatheter
More informationRepair or Replacement
Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division
More informationCONTRIBUTION. Aortic valve replacement in young patients: long-term follow-up
CONTRIBUTION Aortic valve replacement in young patients: long-term follow-up DOUGLAS S. MOODIE, MD; USAMA HANHAN, MD; RICHARD STERBA, MD; DANIEL J. MURPHY, Jr, MD; ELIOT R. ROSENKRANZ, MD; ANDREA M. KOVACS,
More informationValvular Heart Disease and Adult Congenital Intervention. A Pichard, MD. Director Cath Labs, Washington Hospital Center. Georgetown University.
Valvular Heart Disease and Adult Congenital Intervention. A Pichard, MD Director Cath Labs, Washington Hospital Center. ProfessorofMedicine (Cardiology), Georgetown University. Conflict of Interest Proctor
More informationRecommended Monographs and Guidelines on Heart Valve Surgery
Recommended Monographs and Guidelines on Heart Valve Surgery 403 Recommended Monographs and Guidelines Recommended Monographs and Guidelines on Heart Valve Surgery 404 Monographs on Heart Valve Surgery
More informationRepeated mitral valve replacement in a patient with extensive annular calcification
CASE REPORT Open Access Repeated mitral valve replacement in a patient with extensive annular calcification Tadashi Kitamura 1,2*, Sachito Fukuda 1, Takahiro Sawada 1, Sumio Miura 1, Ikutaro Kigawa 1,3
More informationEvolution of prosthetic heart valves L. Henry Edmunds, Jr, MD Philadelphia, Pa
Evolution of prosthetic heart valves L. Henry Edmunds, Jr, MD Philadelphia, Pa Charles Hufnagel developed and successfully implanted the first prosthetic cardiac valve in the descending thoracic aorta
More information10 ο ΣΥΝΕΔΡΙΟ ΕΠΕΜΒΑΤΙΚΗΣ ΚΑΡΔΙΟΛΟΓΙΑΣ ΚΑΙ ΗΛΕΚΤΡΟΦΥΣΙΟΛΟΓΙΑΣ Σεπτεμβρίου 2017 Electra Palace Θεσσαλονικη
10 ο ΣΥΝΕΔΡΙΟ ΕΠΕΜΒΑΤΙΚΗΣ ΚΑΡΔΙΟΛΟΓΙΑΣ ΚΑΙ ΗΛΕΚΤΡΟΦΥΣΙΟΛΟΓΙΑΣ 14-16 Σεπτεμβρίου 2017 Electra Palace Θεσσαλονικη Ηχωκαρδιογραφία στην ένδειξη-προετοιμασία, διενέργεια, παρακολούθηση ασθενών που υποβάλλονται
More information15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses
ORIGINAL CONTRIBUTION 15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses WR Eric Jamieson, MD, Eva Germann, MSc, Michel R Aupart, MD 1, Paul H Neville, MD 1, Michel A Marchand,
More informationIncidence and Management of Early Implant Failure after Transcatheter Aortic Valve Implantation
ESC Congress 2010 28 Aug 2010-01 Sep 2010 Stockholm - Sweden Incidence and Management of Early Implant Failure after Transcatheter Aortic Valve Implantation Gian Paolo Ussia, MD Director of Interventional
More informationHani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia.
Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Decision process for Management of any valve Timing Feasibility
More informationEdwards Transcatheter AVR: Have the Outcomes Changed after CE Approval?
Edwards Transcatheter AVR: Have the Outcomes Changed after CE Approval? Update from PARTNER EU and SOURCE Registries T. Lefèvre Disclosure Statement Cardiologist Interventional cardiologist 1 st PABV in
More informationESC/EACTS Guidelines for the Management of Valvular Heart Disease
ES/EATS Guidelines for the Management of Valvular Heart Disease European Journal of ardio-thoracic Surgery 2012 - Why do we need new guidelines on the management of valvular disease? New evidence has been
More informationMy Choice For Percutaneous Mitral Valve Replacement. Jose Luis Navia, MD.
My Choice For Percutaneous Mitral Valve Replacement Jose Luis Navia, MD. Disclosure Edwards Lifescienses St. Jude Medical MAQUET NaviGate Consultant, Investigator Consultant, Investigator Consultant, Investigator
More informationReoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment
Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment W.R.E. Jamieson, MD; L.H. Burr, MD; R.T. Miyagishima, MD; M.T. Janusz, MD; G.J. Fradet, MD; S.V. Lichtenstein, MD; H. Ling, MD Background
More informationTAVI and Valve Replacement Thromboprophylaxis. Warren Prokopiw Pharmacy Resident
TAVI and Valve Replacement Thromboprophylaxis Warren Prokopiw Pharmacy Resident 2011-2012 Case Mr MW 76 yo Admitted 14 May for worsening CHF PMH: Aortic Stenosis, CVD (CABG x4 1980, PCI x3 stent 2008)
More informationThe stentless bioprosthesis has many salient features that
Aortic Valve Replacement with the Medtronic Freestyle Xenograft Using the Subcoronary Implantation Technique D. Michael Deeb, MD The stentless bioprosthesis has many salient features that make it an attractive
More informationHow to Avoid Prosthesis-Patient Mismatch
How to Avoid Prosthesis-Patient Mismatch Philippe Pibarot, DVM, PhD, FACC, FAHA, FASE, FESC Canada Research Chair in Valvular Heart Diseases INSTITUT UNIVERSITAIRE DE CARDIOLOGIE ET DE PNEUMOLOGIE DE QUÉBEC
More informationThe production of murmurs is due to 3 main factors:
Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or
More informationTAVR: Echo Measurements Pre, Post And Intra Procedure
2017 ASE Florida, Orlando, FL October 10, 2017 8:00 8:25 AM 25 min TAVR: Echo Measurements Pre, Post And Intra Procedure Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology Echo Lab Associate
More informationCardiac catheterisation in AS
AORTIC STENOSIS MANAGEMENT OF VALVULAR AORTIC STENOSIS Dr Badri Paudel Third most common cardiovascular disease Most prevalent valvular heart disease in the world Commonest acquired valvular lesion with
More informationConflict of Interests
Introduction to Interventional Echocardiography Roberto M Lang, MD Tomtec Conflict of Interests Research Grants Philips Medical Imaging Research Grants Speakers bureau Advisory bureau 1 Structural Heart
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/28521 holds various files of this Leiden University dissertation Author: Katsanos, Spyridon Title: Outcomes of transcatheter aortic valve implantation Issue
More informationChoice of Prosthetic Heart Valve in Adults
Journal of the American College of Cardiology Vol. 55, No. 22, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.10.085
More informationTranscatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data
Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data Echo Florida 2013 Jonathan J. Passeri, M.D. Co-Director, Heart Valve Program Director,
More informationDISCLOSURE. Mitral ViV: why? Mitral Valve- in- Valve: Procedural Image Guidance with TEE, a Must Have or Nice to Have? UW Medicine NONE.
Mitral Valve- in- Valve: Procedural Image Guidance with TEE, a Must Have or Nice to Have? G. Burkhard Mackensen, MD, PhD, FASE Professor & Chief, Division of Cardiothoracic Anesthesia, Department of Anesthesiology
More informationEdwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved
Transcatheter Aortic Valve Replacement Symptomatic Aortic Stenosis Asymptomatic Juan Crestanello, MD Interim Director, Division of Cardiac Surgery Associate Professor Division of Cardiac Surgery The Ohio
More informationBY LUCAS W. HENN, MD; RAJ R. MAKKAR, MD, FACC, FSCAI; AND GREGORY P. FONTANA, MD, FACS, FACC
Valve-in-Valve TAVI for Degenerated Surgical Prostheses Transcatheter aortic valve implantation is being used in novel ways to treat degenerated surgical prostheses with promising results. BY LUCAS W.
More informationNext Generation Therapies: Aortic, Mitral and Beyond
Next Generation Therapies: Aortic, Mitral and Beyond Scott M Lilly, MD PhD Medical (Interventional) Director, Structural Heart Program Heart Summit, Lima OH August 26 th, 2017 Next Generation Therapies:
More informationAlec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France
Future Percutaneous Therapies for Mitral Valve Disease (Mitraclip,percutaneous annuloplasty and transcatheter valve implantation) Will they reach the TAVI s success? Alec Vahanian,FESC, FRCP (Edin.) Bichat
More informationPosterior leaflet prolapse is the most common lesion seen
Techniques for Repairing Posterior Leaflet Prolapse of the Mitral Valve Robin Varghese, MD, MS, and David H. Adams, MD Posterior leaflet prolapse is the most common lesion seen in degenerative mitral valve
More informationCLINICAL COMMUNIQUE 16 YEAR RESULTS
CLINICAL COMMUNIQUE 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 Introduction The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 6900, was introduced
More informationValvular Heart Disease
GP Update Refresher 18 th January 2018 Valvular Heart Disease Dr. Alexander Lyon Senior Lecturer and Consultant Cardiologist Clinical Lead in Cardio-Oncology Royal Brompton Hospital, London UK President
More informationΧειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας
Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Dr Χρήστος ΑΛΕΞΙΟΥ MD, PhD, FRCS(Glasgow), FRCS(CTh), CCST(UK) Consultant Cardiothoracic Surgeon Normal Mitral Valve Function Mitral Regurgitation
More informationP have been used for mitral and aortic valve replacement
A -Year Comparison of Mitral Valve Replacement With Carpentier-Edwards and Hancock Porcine Bioprostheses P. Perier, MD, A. Deloche, MD, S. Chauvaud, MD, J. C. Chachques, MD, J. Relland, MD, J. N. Fabiani,
More informationIndications and Late Results of Aortic Valve Repair
Indications and Late Results of Aortic Valve Repair Prof. Gebrine El Khoury Department of Cardiovascular and Thoracic Surgery Cliniques St. Luc Brussels, Belgium Aortic Valve Repair Question # 1 Can the
More informationA new era in cardiac valve surgery has begun...
THE CENTER FOR VALVE SURGERY A new era in cardiac valve surgery has begun... Good Help to Those in Need Rawn Salenger, MD, FACS, Director, The Center for Valve Surgery Edward F. Lundy, MD, PhD, Chief of
More information16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900
CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical
More informationCarpentier-Edwards supra-annular aortic porcine bioprosthesis: Clinical performance over 20 years
Surgery for Acquired Cardiovascular Disease Carpentier-Edwards supra-annular aortic porcine bioprosthesis: Clinical performance over 20 years W. R. Eric Jamieson, MD, Lawrence H. Burr, MD, Robert T. Miyagishima,
More information